Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу ишга иқтибос қилган ишлар

6 та иш

Иш: High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses

  1. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses

    Faiz Ahmad Khan, M Salim, Philipp du Cros +9

    Шарҳ мақолаTuberculosis Research and EpidemiologyEuropean Respiratory Journal20174 иқтибос
    ABI

  2. Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

    James M. Trauer, Jay Achar, Nargiza Parpieva +7

    МақолаTuberculosis Research and EpidemiologyBMC Medicine20163 иқтибос
    ABI

  3. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

    S.K. Abidi, Jay Achar, M.M. Assao Neino +34

    МақолаTuberculosis Research and EpidemiologyEuropean Respiratory Journal20191 иқтибос
    ABI

  4. Factors Associated with Unfavourable Treatment Outcomes in Patients with Tuberculosis: A 16-Year Cohort Study (2005–2020), Republic of Karakalpakstan, Uzbekistan

    Jamshid Gadoev, Damin Asadov, Anthony Harries +11

    МақолаTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20211 иқтибос
    ABI

  5. Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan

    Philipp du Cros, Atadjan Khamraev, Zinaida Tigay +15

    МақолаTuberculosis Research and EpidemiologyERJ Open Research20201 иқтибос
    ABI

  6. Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan

    Shona Horter, Jay Achar, Nell Gray +4

    МақолаTuberculosis Research and EpidemiologyPLoS ONE20201 иқтибос
    ABI